Organogenesis Holding (ORGO) Misses Q2 EPS by 42c

Organogenesis Holding (NASDAQ: ORGO) reported Q2 EPS of ($0.77), $0.42 worse than the analyst estimate of ($0.35). Revenue for the quarter came in at $42.8 million versus the consensus estimate of $54.25 million.

For earnings history and earnings-related data on Organogenesis Holding (ORGO) click here.

You May Also Be Interested In

• JPMorgan Double Downgrades Gulfport Energy (GPOR) to Underweight
• Amgen (AMGN) call put ratio 1 call 1 put
• Citi upgrades Old Dominion Freight Line to Buy with $223 target